Advanced Pain Management Center specializes in interventional pain management for patients in the Stoneham, Massachusetts area. The Advanced Pain Management Center team is dedicated to helping patients beat the pain that’s been holding them back from living a full and healthy life. Pain of all types can be treated, including back pain and sciatica, migraines and headaches, joint pain and arthritis, and much more.
Treatment for pain can include prescription medication, lifestyle adjustments as recommended by Dr. Anil Kumar, and outpatient procedures performed either on-site at Advanced Pain Management Center or at the Northeast Ambulatory Center. Some of the many available procedures include trigger point injections, radiofrequency rhizotomy, lumbar facet joint block, spinal cord stimulator, and stellate ganglion block among many others.
No matter what type of pain is troubling a patient, the team at Advanced Pain Management has the skill and experience to help. Whether the pain is new or it’s been going on for a lifetime, there are solutions available. Reach out to the Advanced Pain Management team anytime to arrange a consultation or appointment.
At Bay State Pain Management, we take a comprehensive approach to treating your pain symptoms. We know that every patient is different and deserves a specific treatment plan based on their unique condition, responses to medication, injections, and physical therapy. If you are suffering with acute or chronic pain, our experienced doctors and staff want to help you find a way to overcome your discomfort, so you can move better and enjoy your favorite activities again.
When people think of pain management, they often assume that prescription medications are their only option if they want to find relief. At Bay State Pain Management, we want to help our patients find the best treatment for them and proudly offer alternative pain management therapies that can have a truly positive impact on your life without relying on medication. Each of our patients receives personalized attention and care, with a plan that is tailored to their individual needs.
There are many different reasons a patient may require the pain management treatments we offer at Bay State Pain Management. Under the guidance of our board-certified pain specialist Dr. Sherif Algendy, our highly-trained medical staff provide you with the understanding and information you need to make informed decisions regarding your treatment and care. We believe in addressing the root cause of your condition while bolstering the body’s natural rejuvenation processes, so you can heal from within.
The compassionate physicians at Bay State Pain Management have helped many patients overcome pain symptoms caused by a wide range of chronic issues including spinal fractures, neuropathies, fibromyalgia, cervical radiculopathy, spondylolisthesis, cancer pain, postherpetic neuralgia, chronic pelvic pain, and many other conditions. No matter what the underlying cause of your pain is, the experienced professionals at Bay State Pain Management can appropriately diagnose and treat your condition in an office that is designed to be efficient and welcoming. We strive to reduce wait times by contacting insurance companies daily in order to obtain pre-approval, so we can get you started on an effective treatment plan as quickly as possible.
Dr. Wuerz graduated from medical school at the University of Tuebingen in Germany. After research at the Massachusetts Institute of Technology and the Massachusetts General Hospital, he completed two years of orthopedic surgery residency at the Inselspital in Berne, Switzerland. He then returned to Boston for a two-year NIH Career Development Grant after earning a master’s degree at the London School of Economics in Health Policy and Economics. He completed an orthopedic surgery residency at the Cleveland Clinic and a sports medicine fellowship at Rush University in Chicago. He was then awarded the traveling fellowship of the International Society of Hip Arthroscopy training at the Steadman Clinic in Vail, Colorado, and the Schulthess Klinik in Zurich, Switzerland, focusing on hip arthroscopy and hip preservation surgery. He started working at the New England Baptist Hospital as an attending physician before joining the Boston Sports and Shoulder Center.
Dr. Wuerz has helped provide care for athletes of all levels including high school, college and professional athletes including from the Chicago Bulls (NBA) and White Sox (MLB). Dr. Wuerz has been the head team physician for Merrimack College for the last three years and is also a hip consultant for the Boston Ballet.
Dr. Wuerz is a member of several professional organizations and previously received a National Institutes of Health (NIH) career development award. He was chosen as the AANA health policy fellow and was also awarded the traveling fellowship of the International Society for Hip Arthroscopy (ISHA).
Dr. Wuerz believes in delivering the best possible patient care taking into account the patient’s lifestyle. To arrive at the proper course of treatment Dr. Wuerz understands that non-operative measures are often the most appropriate treatment. In working on translating the findings of clinical and outcomes studies, Dr. Wuerz strives to educate and provide patients with advanced and up-to-date care.
The Harvard Department of Stem Cell and Regenerative Biology (HSCRB) is committed to advancing biomedical research for the benefit of humankind, and to delivering innovative teaching and training at the interface of biology and medicine.
Our dynamic, collegial department is part of Harvard’s Faculty of Arts and Sciences and Harvard Medical School. This reflects the strategic importance of our work across the university and opens up unrivaled opportunities for meaningful collaboration.
The ultimate goal of HSCRB’s research, whether it is focused on the most basic level of cellular development or on screening chemical compounds for potential drugs, is combating disease and tissue degeneration and improving human health. Research is conducted in our state-of-the-art new laboratories in Cambridge, and in one of Harvard’s affiliated world-class hospitals.
HSCRB is the academic home of 20 faculty and over 350 stem cell scientists conducting research on Harvard’s Cambridge and Longwood campuses as well as Massachusetts General Hospital, Children’s Hospital Boston, Dana Farber Cancer Institute, Brigham & Women’s Hospital, and the Broad Institute. Over 200 HSCRB scientists conduct work in the Bauer-Fairchild laboratories in Cambridge.
HSCRB administrators are dedicated to achieving the Department’s goals in research and education. We support faculty in their roles as scientists, teachers, and University leaders. We support students’ efforts to learn and grow through coursework, lab experiences, and advising. We help each other in labs and offices throughout the Department and University to create a productive, supportive, and collegial work environment.
Please stop by the Administrative Suite in the Bauer Laboratory Building so we can introduce ourselves.
To pursue the promise of stem cell science and regenerative medicine, in 2004 Harvard founded the Harvard Stem Cell Institute (HSCI), a novel network of stem cell scientists that extends from the University to its affiliated hospitals and the biomedical industry. Leveraging its unique environment, HSCI has helped to change the paradigm for biomedical research and education by enabling cross-institutional and cross-disciplinary collaboration and student participation in cutting-edge science.
The Harvard community and the greater Boston area is home to the largest concentration of biomedical researchers in the world, which allows HSCI to advance stem cell biology and translational medicine in a way no other single entity can. Stem cell biologists across all the departments, schools, institutes, and affiliated hospitals of Harvard are able to collaborate on a daily basis with scientist-physicians, chemists, bioengineers, and experts in business, law, and ethics in order to develop tomorrow’s treatments and cures today.
HSCI is focused on bringing stem cell-based treatments to patients as quickly as possible. While continuing to advance scientific discovery, we are developing treatments for diseases of aging, the blood, cancer, metabolism, and neurological disorders. To accomplish this, we bring together more than 1,000 scientists in the schools and affiliated hospitals of Harvard, fund novel research, and implement new collaborative academic and industrial models.
HSCI is funded entirely by private philanthropy and supports discounted rates for its members at several core facilities in the Harvard community: iPS Core Facility; HSCI Therapeutic Screening Center; HSCI Center for Stem Cell Bioinformatics; Center for Human Cell Therapy (CHCT)/Trans Lab; Center for Human Antibody Therapeutics (CHAT); Humanized Neonatal Mouse Center (HNMC); as well as flow cytometry cores at Boston Children’s Hospital, Joslin Diabetes Center, Massachusetts General Hospital, and the Harvard University Department of Stem Cell and Regenerative Biology. Additionally, members of the HSCI research community have access to the production of clinical-grade cellular therapy products through the Connell O’Reilly Cell Manipulation Core Facility (DF/HCC) at DFCI directed by Jerome Ritz, MD, HSCI Executive Committee and Principal Faculty member.
The Hoggatt Laboratory is a stem cell and regenerative biology research group at Harvard Medical School / Massachusetts General Hospital and is affiliated with both the MGH Cancer Center and Center for Transplantation Sciences as well as the Harvard Stem Cell Institute. We are broadly interested in tissue regeneration and stem cell biology, with a particular focus on translational research to enhance bone marrow transplantation.
Research efforts over the last several decades working to develop therapies have largely focused on finding “magic bullets”, a small molecule or perhaps protein biologic that can be given to the patient as a drug to cure their disease. We believe that the cures of the future will come from tapping in to the body’s natural regenerative capacities or will use cellular therapies, namely stem cell transplantation. Our goals are to discover new regenerative pathways within the body to allow for disease correction and to make stem cell transplantation faster, safer, cheaper and better to broaden its use to more patients.
An autologous stem cell transplant (ASCT) is a procedure in which high-dose chemotherapy is used to treat certain cancers. The procedure was formerly known as a bone marrow transplant. However, as hematopoietic (blood-forming) stem cells from the blood are now used, the procedure is referred to as a peripheral blood stem cell transplant.
A stem cell transplant “rescues” your body with an infusion of healthy blood-forming cells following high dose chemotherapy. The infused stem cells migrate to the bone marrow where they produce blood cells that your body and immune system require.
We offer a patient-centered approach that is comprehensive and caring. Our goal is to provide our patients and their families mental, physical and emotional support during a very stressful time. During the hospitalization, a number of doctors participate in the care of transplant patients. Lahey Hospital & Medical Center is a teaching hospital, and inpatients may be seen by physicians-in-training (interns, residents, and fellows) and medical students. In all cases, however, their involvement will be supervised by a physician on the staff of Lahey Hospital & Medical Center.
RESEARCH AT MASS GENERAL
Discover the largest hospital-based research program in the U.S. and how clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and bring the latest advances to patient care
David T. Scadden, M.D.
Gerald and Darlene Jordan Professor of Medicine, Harvard University
Director, Center for Regenerative Medicine, Massachusetts General Hospital
Co-Director, Harvard Stem Cell Institute, Harvard University
Co-Chair, Department of Stem Cell and Regenerative Biology, Harvard University
Chief, Hematologic Malignancies, MGH Cancer Center
Dr. Scadden’s laboratory is focused on hematopoietic stem cell biology. We are trying to solve three problems that limit the ability of stem cells to be used more effectively as therapy. The first is stem cell number. We are using a range of genetic and cell biologic approaches to understand the cell-autonomous and extrinsic regulators of stem cell cycling and self-renewal. Specifically, our group uses both comparative genomics and shRNA forward screening to identify candidate mediators of the self-renewal program in hematopoietic stem cells. Second, we are studying stem cell localization as delivery of stem cells to specific sites is critical for their application clinically. We have identified novel mechanisms regulating the ability of the stem cell to engage its proper niche using genetic models and high resolution in vivo imaging. Third, we are deeply interested in viewing the stem cell through the microenvironment in which it resides. We have defined key elements of the stem cell niche in the bone marrow and how these features may be modified to improve stem cell number and function. We are now applying these to in vitro models adaptable to high throughput chemical and genetic analyses to further understand niche-stem cell interactions and how they might be modified therapeutically.
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
SPINE is a pain center of excellence in a private office setting that was first established by Harvard physicians in 2004. We have since expanded to three locations across Eastern Massachusetts. If you are suffering from pain, training and experience must rank high on your list when choosing a physician to correctly diagnose and treat your pain. Our caring, highly qualified, and skilled ABMS Board Certified and ACGME fellowship-trained Interventional Pain Physician is unique in New England.
We offer the entire spectrum of state-of-the-art minimally invasive spine and pain management procedures to diagnose and treat back and neck pain.
Our mission is to provide up to date, evidence-based, and individualized care for our patients in a comfortable private office setting through a comprehensive multidisciplinary approach to relieve pain, improve function and maximize the quality of life.
We hope to be the answer to your pain. We offer unparalleled service, are easily accessible, and work closely with local community health care providers.